PL366906A1 - Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases - Google Patents

Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases

Info

Publication number
PL366906A1
PL366906A1 PL02366906A PL36690602A PL366906A1 PL 366906 A1 PL366906 A1 PL 366906A1 PL 02366906 A PL02366906 A PL 02366906A PL 36690602 A PL36690602 A PL 36690602A PL 366906 A1 PL366906 A1 PL 366906A1
Authority
PL
Poland
Prior art keywords
imidazotriazinones
derivatives
inflammatory processes
immune diseases
use against
Prior art date
Application number
PL02366906A
Other languages
Polish (pl)
Inventor
Cristina Alonso-Alija
Heike Gielen
Martin Hendrix
Ulrich Niewöhner
Dagmar Schauss
Hilmar Bischoff
Nils Burkhardt
Volker Geiss
Karl-Heinz Schlemmer
Nigel J. Cuthbert
Mary Fitzgerald
Graham Sturton
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of PL366906A1 publication Critical patent/PL366906A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
PL02366906A 2001-06-01 2002-05-17 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases PL366906A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0113344.6A GB0113344D0 (en) 2001-06-01 2001-06-01 Novel heterocycles 3

Publications (1)

Publication Number Publication Date
PL366906A1 true PL366906A1 (en) 2005-02-07

Family

ID=9915717

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02366906A PL366906A1 (en) 2001-06-01 2002-05-17 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases

Country Status (28)

Country Link
US (2) US7115602B2 (en)
EP (1) EP1399447A1 (en)
JP (1) JP2004536078A (en)
KR (1) KR20040023605A (en)
CN (1) CN1512993A (en)
BG (1) BG108381A (en)
BR (1) BR0210910A (en)
CA (1) CA2449095A1 (en)
CO (1) CO5540381A2 (en)
CZ (1) CZ295609B6 (en)
EC (1) ECSP034872A (en)
EE (1) EE200300570A (en)
GB (1) GB0113344D0 (en)
GT (1) GT200200099A (en)
HR (1) HRP20031090A2 (en)
HU (1) HUP0400773A3 (en)
MX (1) MXPA03010985A (en)
NO (1) NO20035324L (en)
NZ (1) NZ529848A (en)
PE (1) PE20030231A1 (en)
PL (1) PL366906A1 (en)
RU (1) RU2003138078A (en)
SK (1) SK14672003A3 (en)
SV (1) SV2003001061A (en)
UA (1) UA75149C2 (en)
UY (1) UY27312A1 (en)
WO (1) WO2002098879A1 (en)
ZA (1) ZA200309111B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2388111A (en) * 2002-05-01 2003-11-05 Bayer Ag Novel imidazotriazinone compounds
GB2388594A (en) * 2002-05-16 2003-11-19 Bayer Ag Imidazo-triazine PDE 4 inhibitors
FR2850653A1 (en) * 2003-02-04 2004-08-06 Univ Pasteur New 4-aminopyrazol-(1,5-a)-1,3,5-triazine derivatives, are potent and selective phosphodiesterase 4 inhibitors useful e.g. for treating CNS disorders, neuroinflammation, Crohn's disease, asthma, cancer or epilepsy
JP2006219374A (en) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Imidazotriazinone derivative having pde 7 inhibition
TW200745106A (en) * 2005-10-03 2007-12-16 Astrazeneca Ab Chemical compounds
EP2685983B1 (en) 2011-03-17 2016-05-18 Algiax Pharmaceuticals GmbH Novel use of imidazotriazinones
WO2013156231A1 (en) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Use of imidazotriazinones in neuropathic pain
WO2015144598A1 (en) * 2014-03-28 2015-10-01 Algiax Pharmaceuticals Gmbh Treatment of cognitive disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (en) * 1971-11-19 1973-05-07 Allen & Hanburys Ltd HETEROCYCLIC COMPOUNDS
GB1457873A (en) 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DK109578A (en) 1977-03-25 1978-09-26 Allen & Hanburys Ltd PROCEDURE FOR MAKING HETEROCYCLIC COMPOUNDS
DK1049695T3 (en) * 1997-11-12 2002-05-13 Bayer Ag 2-Phenyl-substituted imidazotriazinones as phosphodiesterase inhibitors
DE19827640A1 (en) * 1998-06-20 1999-12-23 Bayer Ag New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction
US6503908B1 (en) * 1999-10-11 2003-01-07 Pfizer Inc Pharmaceutically active compounds

Also Published As

Publication number Publication date
BG108381A (en) 2004-11-30
JP2004536078A (en) 2004-12-02
ZA200309111B (en) 2004-11-24
CN1512993A (en) 2004-07-14
MXPA03010985A (en) 2004-10-28
US20030139415A1 (en) 2003-07-24
CA2449095A1 (en) 2002-12-12
GT200200099A (en) 2003-02-13
HUP0400773A2 (en) 2004-07-28
BR0210910A (en) 2004-06-08
UA75149C2 (en) 2006-03-15
US20050065153A1 (en) 2005-03-24
RU2003138078A (en) 2005-05-27
HUP0400773A3 (en) 2007-09-28
NO20035324D0 (en) 2003-11-28
HRP20031090A2 (en) 2005-08-31
ECSP034872A (en) 2004-01-28
SV2003001061A (en) 2003-03-18
CO5540381A2 (en) 2005-07-29
KR20040023605A (en) 2004-03-18
PE20030231A1 (en) 2003-05-16
EP1399447A1 (en) 2004-03-24
UY27312A1 (en) 2003-02-28
CZ295609B6 (en) 2005-08-17
EE200300570A (en) 2004-04-15
SK14672003A3 (en) 2004-08-03
NZ529848A (en) 2006-02-24
WO2002098879A1 (en) 2002-12-12
GB0113344D0 (en) 2001-07-25
NO20035324L (en) 2003-11-28
CZ20033275A3 (en) 2004-03-17
US7115602B2 (en) 2006-10-03

Similar Documents

Publication Publication Date Title
SI1352895T1 (en) Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
PL369867A1 (en) Bicyclic oxopyridine and oxopyrimidine derivatives
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
EP1367060A4 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
EP1364957A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
EP1364958A4 (en) Glycopyranosyloxypyrazole derivatives and medicinal use thereof
AU2003284808A8 (en) The derivatives of pyridone and the use of them
PL362984A1 (en) Compounds useful in the treatment of inflammatory diseases
AU2003216592A8 (en) Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
NO20034159D0 (en) The estrogen-gestagen combination preparation and its use
HRP20031091A2 (en) Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
AU2002247973A1 (en) Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases
PL366906A1 (en) Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
EP1392317A4 (en) Substituted 1-benzazepines and derivatives thereof
EP1472273A4 (en) Compositions and methods for the treatment of immune related diseases
HUP0303612A3 (en) Bicyclic guanidine derivatives and their therapeutic use
GB0111496D0 (en) Therapeutic systems and methods
GB0120009D0 (en) Cause and effect diagnosis
EP1367123A4 (en) Neurotonin and use thereof
EP1392460A4 (en) Hydrogenfluorides of aminosilanols and their use
AU2002302618A1 (en) 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
GB0200843D0 (en) Benzodioxinopyrroles their preparation and use
GB0112236D0 (en) Compounds and their therapeutic use

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)